The science of precision ultrasonography of the eye was developed under the leadership of Drs. Jack Coleman, Fred Lizzi, Ron Silverman and others at Cornell University beginning in the late 1970s. In 1991 they were joined by Dan Z. Reinstein, who had just started a fellowship at Cornell. Dr. Reinstein was fascinated by the idea of mapping the corneal epithelium, which had not yet been achieved by any technology. He and Dr. Silverman developed a way of mapping the epithelium of the cornea over a 3mm central zone providing the first in vivo map of the epithelium. The team later developed the first prototype arc scan device which had the ability to map the entire 10-mm diameter of the cornea as well as the anterior segment. The team, now joined by Hugo Sutton, MD formed a company called Ultralink LLC to develop the first commercial prototype devices. UltraLink attempted to market the product under the name Artemis 2 but did not succeed in commercialization.
ArcScan was founded in February 2007 in Golden, Colorado in cooperation with Cornell to redesign the Artemis 2 by leveraging the technology and knowledge of the Cornell researchers. UltraLink and its patent licenses were acquired by ArcScan in the fall of 2007. ArcScan partnered with Evergreen Research Inc. (ERI) of Golden Colorado to undertake the complete redesign of the Artemis 2 with the goal of improving image quality, ease of use and reliability. Over the next few years, ERI added several innovations to the Artemis design including the ability to image the posterior surface of the lens. Many of these innovations led to a number of issued and pending ArcScan patents.
ArcScan has continued the association with Professors Coleman and Silverman, currently at Columbia University, in order to further develop the technology and refine the usability of the product. Prof. Dan Z. Reinstein, who is the Director of the London Vision Clinic, was appointed Chief Medical Officer of ArcScan in May 2015. Dan has continued his research in close partnership with the Columbia and ERI teams. Through their efforts, they have substantially improved a number of unique and critical applications for very high frequency digital ultrasound imaging, including screening for keratoconus using epithelial thickness maps, diagnosis and therapeutic treatment of irregularly irregular astigmatism, and improving the safety of phakic IOL surgery by accurate posterior segment lens sizing. In the process, over 70 peer-reviewed publications using this technology have been published to date.
Throughout this time ArcScan has invested heavily in advancing its core science and technology, resulting in the development of ArcScan’s intelligent ultrasound visualization technology. Due to the success of accommodating intraocular lenses and the ever growing LASIK surgery market, intelligent imaging today is more relevant than ever before. As surgeons aim to perfect outcomes for their patients and ensure a maximum level of safety, ArcScan’s Insight 100 System is designed to aid in achieving these goals.
Thanks to the relentless passion and dedication of the team at Evergreen Research, Prof. Silverman at Columbia, Prof. Reinstein at the London Vision Clinic and the ArcScan Board of Directors, ArcScan has turned a vision into reality. Special thanks are due to Mr. Allan F. Brown who has supported ArcScan financially through many difficult times. The people at and around ArcScan have always believed in the need for our technology and its ability to enable surgeons to ultimately deliver better medicine to their patients.